The Effect of Pharmacist Intervention on Blood Pressure Control (AFenPA)
Recruitment status was Active, not recruiting
The purpose of the study is to test if a Pharmacist Intervention Program with home blood pressure monitoring (HBPM) improves or controls pharmacological adherence and blood pressure levels in hypertensive patients under pharmacological treatment, compared to those who receive usual care in a community pharmacy setting.
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
|Official Title:||Pharmacist Intervention Effect on the Medication Adherence and Blood Pressure Control in Treated Patients|
- blood pressure control [ Time Frame: At 6 months ] [ Designated as safety issue: No ]Percentage of patients with controlled hypertension
- Adherence [ Time Frame: At 6 months ] [ Designated as safety issue: No ]Percentage of adherent patients after 6 months within the trial
|Study Start Date:||February 2010|
|Estimated Study Completion Date:||September 2011|
|Estimated Primary Completion Date:||September 2011 (Final data collection date for primary outcome measure)|
The intervention group receive an pharmacist intervention (health education, Home Blood Pressure Monitoring and Referral to physician as needed) This group will be followed for 6 months
Behavioral: Health education, Home blood pressure monitoring
Health education (on hypertension, smoking, healthy diet, obesity, physical inactivity and adherence to antihypertensive medications and home blood pressure monitoring) . The patient will be referred to physician when needed. The patient will be followed up during 6 months.
Other Name: pharmaceutical health education
No Intervention: Control
The control group receive usual care in the community pharmacy
Hypertension is a major health concern worldwide due to its deleterious impact on the population in terms of excessive morbidity and mortality, especially when there is insufficient hypertension control and prevention at the community level.
|Granada, Andalucia, Spain, 18000|
|Jaén, Andalucia, Spain, 23000|
|Study Director:||Maria Jose Faus, PhD||Universidad de Granada|